Primary Category:
Treatment Protocols
Disease Category:
Follicular Lymphoma, Lymphoma, Non-Hodgkin Lymphoma
Status:
Open
Randomized Phase II Trial in Early Relapsing or Refractory Follicular Lymphoma
S1608 is reopened to accrual, effective March 10, 2023, at 12:00 pm Pacific Time.
NCT#03269669
